Muscular dystrophy and myopathy_Paediatric
Gene: CASQ1
PMID- 38982518 de Feraudy - paper on undiagnosed congenital myopathy, however late-onset muscle weakness patients were also enrolled. Two individuals with variants in CASQ1 are in the supplementary information, with it saying onset in infancy in one and onset in adulthood in the other. It is referencing patients from PMID- 29039140; Bohm.
Bohm - family 1: 7 affected individuals, onset between early 20's and mid-40's. Family 2: 1 individual, onset early 50's. Family 2 is the case listed as infancy onset in de Feraudy. All affected individuals in this paper are said to have had normal birth, early childhood and motor milestonesCreated: 17 Jul 2025, 3:59 a.m. | Last Modified: 17 Jul 2025, 3:59 a.m.
Panel Version: 1.96
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Myopathy, vacuolar, with CASQ1 aggregates 616231
Publications
2 cases have been reported with congenital myopathy. Gain of function is expected to be the mechanism of disease.
Sources: LiteratureCreated: 1 Aug 2024, 2:14 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
tubular aggregate myopathy MONDO:0008051
Publications
Mode of pathogenicity
Other
Variants in this GENE are reported as part of current diagnostic practice
OMIM notes adult onset
PMID: 30258016 - 22 patients (12 families) where 21/22 carried a founder mutation p.Asp244Gly.
- Patients presented with adult onset proximal weakness, quadricep atrophy and 3/22 with cardiac involvement.
- Some patients were asymptomatic and diagnosed by elevated creatine kinase.
- Youngest age at onset was 12 years old, but only 2/22 were symptomatic <30 years of age.
PMID: 25116801 - 8 patients (4 families) with mild myopathy. All patients were heterozygous for the founder mutation p.Asp244Gly. Patients were aged 23-58 years old at the time of analysis, none mentioned to have childhood onset.
PMID: 26136523 - functionally shows that missense cause both wildtype and mutation protein to aggregate and mislocalise -> evidence of dominant negative mechanism. Lack of NMD predicted variants supports this finding.
Summary: Rare reports of childhood onset, mostly adult
Sources: Expert listCreated: 15 Jun 2020, 4:06 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Phenotypes
Myopathy, vacuolar, with CASQ1 aggregates 616231
Publications
Mode of pathogenicity
Other
Gene: casq1 has been classified as Amber List (Moderate Evidence).
Gene: casq1 has been classified as Amber List (Moderate Evidence).
gene: CASQ1 was added gene: CASQ1 was added to Muscular dystrophy and myopathy_Paediatric. Sources: Literature Mode of inheritance for gene: CASQ1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: CASQ1 were set to 38982518 Phenotypes for gene: CASQ1 were set to tubular aggregate myopathy MONDO:0008051 Mode of pathogenicity for gene: CASQ1 was set to Other Review for gene: CASQ1 was set to AMBER gene: CASQ1 was marked as current diagnostic